Patients lose access to free medicines amid spat between drugmakers, health plans

Wall Street Journal

2 May 2023 - Pharmaceutical companies have cut financial assistance to thwart health plan tactics.

It is getting tougher for people taking expensive medicines to get financial help from drug makers.

Johnson & Johnson, Pfizer and other pharmaceutical companies are scaling back programs that cover the copayments of patients or provide free drugs. The programs have been costing drugmakers billions of dollars a year and have been increasing as health plans seeking to control their own spending have tried to take advantage of the assistance.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder